Gliclazide is primarily used in the management of type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, which helps lower blood sugar levels. This medication is often prescribed when diet, exercise, and other lifestyle changes are not sufficient to control blood glucose levels. It is particularly effective in patients who retain some pancreatic beta-cell function. Gliclazide is also known for its additional benefits, such as improving insulin sensitivity and reducing the risk of diabetic complications like retinopathy and nephropathy. It is usually taken orally, and the dosage is tailored to the individual’s needs based on their blood sugar levels and response to treatment. Regular monitoring of blood glucose is essential to ensure optimal dosing and to avoid hypoglycemia, a potential side effect. Additionally, gliclazide is sometimes preferred over other sulfonylureas due to its lower risk of causing severe hypoglycemia and its antioxidant properties, which may provide added protection against oxidative stress in diabetic patients.